Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Insmed ROE 2010-2024 | INSM

Current and historical return on equity (ROE) values for Insmed (INSM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Insmed ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-06-30 $-0.80B $0.04B 306.78%
2024-03-31 $-0.75B $-0.47B 240.58%
2023-12-31 $-0.75B $-0.33B 364.96%
2023-09-30 $-0.72B $-0.29B 720.40%
2023-06-30 $-0.70B $-0.16B 1946.85%
2023-03-31 $-0.55B $-0.05B -3838.60%
2022-12-31 $-0.48B $0.09B -868.47%
2022-09-30 $-0.44B $-0.03B -319.85%
2022-06-30 $-0.42B $0.04B -154.59%
2022-03-31 $-0.44B $0.12B -111.88%
2021-12-31 $-0.44B $0.41B -105.58%
2021-09-30 $-0.42B $0.51B -112.02%
2021-06-30 $-0.38B $0.53B -109.81%
2021-03-31 $-0.32B $0.20B -103.23%
2020-12-31 $-0.29B $0.28B -94.46%
2020-09-30 $-0.25B $0.36B -79.61%
2020-06-30 $-0.24B $0.41B -82.17%
2020-03-31 $-0.25B $0.21B -87.43%
2019-12-31 $-0.26B $0.26B -95.60%
2019-09-30 $-0.29B $0.30B -116.09%
2019-06-30 $-0.32B $0.36B -128.40%
2019-03-31 $-0.33B $0.14B -130.18%
2018-12-31 $-0.33B $0.21B -99.62%
2018-09-30 $-0.30B $0.29B -81.76%
2018-06-30 $-0.26B $0.37B -64.23%
2018-03-31 $-0.22B $0.44B -68.92%
2017-12-31 $-0.19B $0.36B -77.81%
2017-09-30 $-0.20B $0.42B -100.00%
2017-06-30 $-0.19B $0.08B -130.33%
2017-03-31 $-0.18B $0.12B -96.64%
2016-12-31 $-0.18B $0.15B -78.23%
2016-09-30 $-0.14B $0.22B -52.68%
2016-06-30 $-0.13B $0.25B -44.93%
2016-03-31 $-0.13B $0.28B -38.52%
2015-12-31 $-0.12B $0.31B -39.97%
2015-09-30 $-0.11B $0.34B -39.81%
2015-06-30 $-0.10B $0.37B -42.84%
2015-03-31 $-0.09B $0.17B -55.59%
2014-12-31 $-0.08B $0.19B -50.24%
2014-09-30 $-0.08B $0.20B -52.56%
2014-06-30 $-0.07B $0.11B -51.47%
2014-03-31 $-0.06B $0.13B -41.71%
2013-12-31 $-0.06B $0.14B -43.66%
2013-09-30 $-0.06B $0.16B -44.81%
2013-06-30 $-0.05B $0.11B -39.92%
2013-03-31 $-0.05B $0.11B -39.51%
2012-12-31 $-0.04B $0.12B -32.41%
2012-09-30 $-0.03B $0.14B -26.20%
2012-06-30 $-0.06B $0.12B -45.80%
2012-03-31 $-0.06B $0.13B -41.31%
2011-12-31 $-0.07B $0.13B -43.19%
2011-09-30 $-0.07B $0.14B -38.40%
2011-06-30 $-0.03B $0.18B -18.80%
2011-03-31 $-0.02B $0.19B -14.01%
2010-12-31 $-0.01B $0.19B -4.24%
2010-09-30 $0.00B $0.13B 1.61%
2010-06-30 $0.00B $0.12B 1.62%
2010-03-31 $0.00B $0.12B 0.00%
2009-12-31 $0.12B $0.12B 97.93%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.193B $0.305B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $169.796B 16.99
Vertex Pharmaceuticals (VRTX) United States $121.401B 0.00
Gilead Sciences (GILD) United States $109.659B 18.74
Bristol Myers Squibb (BMY) United States $106.438B 38.32
Regeneron Pharmaceuticals (REGN) United States $102.224B 24.14
CSL (CSLLY) Australia $92.818B 0.00
GSK (GSK) United Kingdom $79.109B 9.18
Alnylam Pharmaceuticals (ALNY) United States $36.549B 0.00
Argenex SE (ARGX) Netherlands $33.060B 0.00
BioNTech SE (BNTX) Germany $27.108B 0.00
Biogen (BIIB) United States $26.725B 11.28
Illumina (ILMN) United States $23.258B 158.70
Moderna (MRNA) United States $21.226B 0.00
BeiGene (BGNE) Cayman Islands $21.078B 0.00
Genmab (GMAB) Denmark $15.300B 19.11
Incyte (INCY) United States $14.175B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.275B 30.93
Exact Sciences (EXAS) United States $12.867B 0.00
Sarepta Therapeutics (SRPT) United States $12.418B 283.07
Vaxcyte (PCVX) United States $11.782B 0.00
Bio-Techne Corp (TECH) United States $11.223B 43.94
QIAGEN (QGEN) Netherlands $9.546B 20.16
Bio-Rad Laboratories (BIO.B) United States $9.332B 30.92
Roivant Sciences (ROIV) United Kingdom $8.564B 0.00
Revolution Medicines (RVMD) United States $8.422B 0.00
Legend Biotech (LEGN) United States $8.288B 0.00
Exelixis (EXEL) United States $8.195B 18.66
Viking Therapeutics (VKTX) United States $8.174B 0.00
Intra-Cellular Therapies (ITCI) United States $8.110B 0.00
Ascendis Pharma (ASND) Denmark $7.688B 0.00
Repligen (RGEN) United States $7.554B 115.27
Halozyme Therapeutics (HALO) United States $6.415B 16.88
Zealand Pharma (ZLDPF) Denmark $6.123B 0.00
Cytokinetics (CYTK) United States $6.061B 0.00
Nuvalent (NUVL) United States $5.891B 0.00
Blueprint Medicines (BPMC) United States $5.283B 0.00
Krystal Biotech (KRYS) United States $5.063B 338.88
Avidity Biosciences (RNA) United States $4.894B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.866B 0.00
Biohaven (BHVN) United States $4.817B 0.00
Arcellx (ACLX) United States $4.690B 0.00
Immunovant (IMVT) United States $4.373B 0.00
Axsome Therapeutics (AXSM) United States $4.291B 0.00
Alkermes (ALKS) Ireland $4.278B 14.37
CRISPR Therapeutics AG (CRSP) Switzerland $4.162B 0.00
Denali Therapeutics (DNLI) United States $3.933B 0.00
ImmunityBio (IBRX) United States $3.908B 0.00
ADMA Biologics Inc (ADMA) United States $3.895B 64.27
Merus (MRUS) Netherlands $3.541B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.416B 0.00
Amicus Therapeutics (FOLD) United States $3.408B 0.00
Apellis Pharmaceuticals (APLS) United States $3.338B 0.00
Edgewise Therapeutics (EWTX) United States $3.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.165B 0.00
Zai Lab (ZLAB) China $3.131B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.079B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.029B 0.00
Iovance Biotherapeutics (IOVA) United States $3.025B 0.00
Kymera Therapeutics (KYMR) United States $2.994B 0.00
Protagonist Therapeutics (PTGX) United States $2.853B 18.49
Janux Therapeutics (JANX) United States $2.828B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.735B 0.00
Guardant Health (GH) United States $2.681B 0.00
Geron (GERN) United States $2.568B 0.00
Apogee Therapeutics (APGE) United States $2.535B 0.00
IDEAYA Biosciences (IDYA) United States $2.523B 0.00
Twist Bioscience (TWST) United States $2.499B 0.00
Scholar Rock Holding (SRRK) United States $2.475B 0.00
Bavarian Nordic (BVNRY) Denmark $2.471B 13.23
ACADIA Pharmaceuticals (ACAD) United States $2.445B 81.89
CG Oncology (CGON) United States $2.428B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.358B 19.66
Vera Therapeutics (VERA) United States $2.356B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.317B 0.00
Keros Therapeutics (KROS) United States $2.257B 0.00
Vericel (VCEL) United States $2.247B 0.00
SpringWorks Therapeutics (SWTX) United States $2.238B 0.00
Structure Therapeutics (GPCR) United States $2.233B 0.00
Akero Therapeutics (AKRO) United States $2.203B 0.00
Belite Bio (BLTE) United States $2.136B 0.00
Ligand Pharmaceuticals (LGND) United States $2.111B 35.88
Myriad Genetics (MYGN) United States $2.023B 0.00
MannKind (MNKD) United States $1.889B 68.70
Arvinas (ARVN) United States $1.888B 0.00
Galapagos (GLPG) Belgium $1.881B 0.00
Neumora Therapeutics (NMRA) United States $1.877B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.863B 0.00
WAVE Life Sciences (WVE) Singapore $1.846B 0.00
NovoCure (NVCR) Jersey $1.828B 0.00
Beam Therapeutics (BEAM) United States $1.827B 0.00
Nurix Therapeutics (NRIX) United States $1.785B 0.00
Celldex Therapeutics (CLDX) United States $1.780B 0.00
NeoGenomics (NEO) United States $1.733B 0.00
Spyre Therapeutics (SYRE) United States $1.721B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.669B 0.00
Certara (CERT) United States $1.665B 54.47
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.657B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.636B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.624B 0.00
Novavax (NVAX) United States $1.612B 0.00
Fortrea Holdings (FTRE) United States $1.589B 49.25
Rocket Pharmaceuticals (RCKT) United States $1.579B 0.00
Dynavax Technologies (DVAX) United States $1.548B 107.36
Intellia Therapeutics (NTLA) United States $1.523B 0.00
Arcus Biosciences (RCUS) United States $1.500B 0.00
Viridian Therapeutics (VRDN) United States $1.453B 0.00
Travere Therapeutics (TVTX) United States $1.405B 0.00
Gyre Therapeutics (GYRE) United States $1.399B 0.00
Disc Medicine (IRON) United States $1.364B 0.00
Kura Oncology (KURA) United States $1.330B 0.00
Cogent Biosciences (COGT) United States $1.313B 0.00
Upstream Bio (UPB) United States $1.292B 0.00
Praxis Precision Medicines (PRAX) United States $1.261B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.259B 0.00
ANI Pharmaceuticals (ANIP) United States $1.242B 16.86
Bicara Therapeutics (BCAX) United States $1.224B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.162B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.155B 0.00
Immatics (IMTX) Germany $1.117B 0.00
ArriVent BioPharma (AVBP) United States $1.049B 0.00
Vir Biotechnology (VIR) United States $1.040B 0.00
Mesoblast (MESO) Australia $1.034B 0.00
CARGO Therapeutics (CRGX) United States $1.034B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.030B 0.00
IGM Biosciences (IGMS) United States $1.024B 0.00
Applied Therapeutics (APLT) United States $1.005B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.001B 0.00
Prothena (PRTA) Ireland $0.983B 0.00
Cullinan Therapeutics (CGEM) United States $0.981B 0.00
Zymeworks (ZYME) United States $0.973B 0.00
Castle Biosciences (CSTL) United States $0.933B 0.00
Rapport Therapeutics (RAPP) United States $0.928B 0.00
Pliant Therapeutics (PLRX) United States $0.895B 0.00
Tyra Biosciences (TYRA) United States $0.893B 0.00
BioAge Labs (BIOA) United States $0.859B 0.00
MiMedx (MDXG) United States $0.853B 24.21
Liquidia Technologies (LQDA) United States $0.848B 0.00
AnaptysBio (ANAB) United States $0.845B 0.00
Sana Biotechnology (SANA) United States $0.841B 0.00
Replimune (REPL) United States $0.839B 0.00
AbCellera Biologics (ABCL) Canada $0.834B 0.00
Zenas BioPharma (ZBIO) United States $0.819B 0.00
Dianthus Therapeutics (DNTH) United States $0.815B 0.00
89BIO (ETNB) United States $0.805B 0.00
Annexon (ANNX) United States $0.800B 0.00
Pacira BioSciences (PCRX) United States $0.792B 7.50
Erasca (ERAS) United States $0.791B 0.00
LENZ Therapeutics (LENZ) United States $0.776B 0.00
Arbutus Biopharma (ABUS) United States $0.763B 0.00
CorMedix Inc (CRMD) United States $0.749B 0.00
Immunome (IMNM) United States $0.733B 0.00
MBX Biosciences (MBX) United States $0.696B 0.00
Adaptive Biotechnologies (ADPT) United States $0.695B 0.00
Mineralys Therapeutics (MLYS) United States $0.694B 0.00
Oculis Holding AG (OCS) Switzerland $0.687B 0.00
Olema Pharmaceuticals (OLMA) United States $0.679B 0.00
Astria Therapeutics (ATXS) United States $0.677B 0.00
Abivax SA (ABVX) France $0.671B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.657B 0.00
Stoke Therapeutics (STOK) United States $0.653B 0.00
Avid Bioservices (CDMO) United States $0.649B 0.00
CureVac (CVAC) Germany $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Tango Therapeutics (TNGX) United States $0.643B 0.00
Entrada Therapeutics (TRDA) United States $0.643B 5.84
ACELYRIN, INC (SLRN) United States $0.639B 0.00
Humacyte (HUMA) United States $0.635B 0.00
Oric Pharmaceuticals (ORIC) United States $0.635B 0.00
Cytek Biosciences (CTKB) United States $0.633B 0.00
Revance Therapeutics (RVNC) United States $0.620B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.618B 0.00
Tectonic Therapeutic (TECX) United States $0.604B 0.00
Third Harmonic Bio (THRD) United States $0.599B 0.00
Celcuity (CELC) United States $0.589B 0.00
Pharming Group (PHAR) Netherlands $0.589B 0.00
Nuvation Bio (NUVB) United States $0.588B 0.00
Neurogene (NGNE) United States $0.587B 0.00
Allogene Therapeutics (ALLO) United States $0.586B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.575B 0.00
Alumis (ALMS) United States $0.574B 0.00
Q32 Bio (QTTB) United States $0.569B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.556B 0.00
Aura Biosciences (AURA) United States $0.531B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.528B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.515B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.500B 0.00
PureTech Health (PRTC) United States $0.496B 0.00
Emergent Biosolutions (EBS) United States $0.494B 0.00
Alector (ALEC) United States $0.493B 0.00
Prime Medicine (PRME) United States $0.490B 0.00
Anavex Life Sciences (AVXL) United States $0.485B 0.00
Terns Pharmaceuticals (TERN) United States $0.484B 0.00
Cartesian Therapeutics (RNAC) United States $0.478B 0.00
Absci (ABSI) United States $0.474B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.465B 0.00
Foghorn Therapeutics (FHTX) United States $0.452B 0.00
REGENXBIO (RGNX) United States $0.448B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.445B 0.00
Contineum Therapeutics (CTNM) United States $0.441B 0.00
Biomea Fusion (BMEA) United States $0.437B 0.00
Semper Paratus Acquisition (TVGN) United States $0.435B 0.00
GH Research (GHRS) Ireland $0.421B 0.00
Sangamo Therapeutics (SGMO) United States $0.416B 0.00
C4 Therapeutics (CCCC) United States $0.409B 0.00
GRAIL (GRAL) United States $0.403B 0.00
EnGene Holdings (ENGN) Canada $0.398B 0.00
Voyager Therapeutics (VYGR) United States $0.386B 25.25
MeiraGTx Holdings (MGTX) United States $0.380B 0.00
Alpha Teknova (TKNO) United States $0.376B 0.00
MaxCyte (MXCT) United States $0.375B 0.00
XOMA Royalty (XOMA) United States $0.374B 0.00
Anika Therapeutics (ANIK) United States $0.363B 175.14
Northwest Biotherapeutics (NWBO) United States $0.358B 0.00
Nautilus Biotechnology (NAUT) United States $0.347B 0.00
Jasper Therapeutics (JSPR) United States $0.338B 0.00
Rezolute (RZLT) United States $0.318B 0.00
Kamada (KMDA) Israel $0.316B 20.37
ITeos Therapeutics (ITOS) United States $0.313B 0.00
UniQure (QURE) Netherlands $0.313B 0.00
Fate Therapeutics (FATE) United States $0.310B 0.00
Design Therapeutics (DSGN) United States $0.306B 0.00
Zura Bio (ZURA) United States $0.301B 0.00
AC Immune (ACIU) Switzerland $0.298B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.291B 0.00
Sutro Biopharma (STRO) United States $0.291B 0.00
Inozyme Pharma (INZY) United States $0.290B 0.00
Urogen Pharma (URGN) United States $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.286B 0.00
Abeona Therapeutics (ABEO) United States $0.285B 0.00
Prima BioMed (IMMP) Australia $0.282B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.282B 0.00
Ocugen (OCGN) United States $0.277B 0.00
BioStem Technologies (BSEM) $0.277B 43.50
GENFIT S.A (GNFT) France $0.275B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.273B 0.00
Climb Bio (CLYM) United States $0.271B 0.00
Opthea (OPT) Australia $0.267B 0.00
Artiva Biotherapeutics (ARTV) United States $0.264B 0.00
Editas Medicine (EDIT) United States $0.257B 0.00
ATyr Pharma (ATYR) United States $0.252B 0.00
TScan Therapeutics (TCRX) United States $0.252B 0.00
Amarin (AMRN) Ireland $0.251B 0.00
2seventy Bio (TSVT) United States $0.248B 0.00
Nkarta (NKTX) United States $0.241B 0.00
Mersana Therapeutics (MRSN) United States $0.238B 0.00
Poseida Therapeutics (PSTX) United States $0.238B 0.00
PepGen (PEPG) United States $0.237B 0.00
Compass Therapeutics (CMPX) United States $0.234B 0.00
Inhibrx Biosciences (INBX) United States $0.233B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.232B 0.00
Kyverna Therapeutics (KYTX) United States $0.231B 0.00
Molecular Partners AG (MOLN) Switzerland $0.228B 0.00
Codexis (CDXS) United States $0.226B 0.00
Instil Bio (TIL) United States $0.224B 0.00
Trevi Therapeutics (TRVI) United States $0.224B 0.00
CAMP4 Therapeutics (CAMP) United States $0.222B 0.00
ScPharmaceuticals (SCPH) United States $0.222B 0.00
Eton Pharmaceuticals (ETON) United States $0.221B 0.00
Solid Biosciences (SLDB) United States $0.220B 0.00
XBiotech (XBIT) United States $0.218B 0.00
Precigen (PGEN) United States $0.213B 0.00
Lifecore Biomedical (LFCR) United States $0.211B 0.00
Gossamer Bio (GOSS) United States $0.207B 0.00
Kodiak Sciences (KOD) United States $0.207B 0.00
Cabaletta Bio (CABA) United States $0.205B 0.00
Fulcrum Therapeutics (FULC) United States $0.202B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.202B 0.00
Bright Minds Biosciences (DRUG) United States $0.200B 0.00
Scilex Holding (SCLX) United States $0.191B 0.00
Greenwich LifeSciences (GLSI) United States $0.186B 0.00
DiaMedica Therapeutics (DMAC) United States $0.185B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.180B 0.00
Adocia (ADOCY) France $0.180B 0.00
Sagimet Biosciences (SGMT) United States $0.179B 0.00
Candel Therapeutics (CADL) United States $0.175B 0.00
Actuate Therapeutics (ACTU) United States $0.175B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.174B 0.00
Checkpoint Therapeutics (CKPT) United States $0.173B 0.00
Ventyx Biosciences (VTYX) United States $0.169B 0.00
Black Diamond Therapeutics (BDTX) United States $0.162B 0.00
Adverum Biotechnologies (ADVM) United States $0.161B 0.00
Generation Bio (GBIO) United States $0.160B 0.00
Skye Bioscience (SKYE) United States $0.158B 0.00
Tenaya Therapeutics (TNYA) United States $0.155B 0.00
Repare Therapeutics (RPTX) Canada $0.152B 0.00
Vigil Neuroscience (VIGL) United States $0.151B 0.00
Innate Pharma S.A (IPHA) France $0.150B 0.00
Compugen (CGEN) Israel $0.149B 0.00
Nuvectis Pharma (NVCT) United States $0.147B 0.00
Cardiff Oncology (CRDF) United States $0.145B 0.00
Verastem (VSTM) United States $0.145B 0.00
Inovio Pharmaceuticals (INO) United States $0.144B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.142B 0.00
Akoya Biosciences (AKYA) United States $0.141B 0.00
Inventiva S.A (IVA) France $0.141B 0.00
Adagene (ADAG) China $0.137B 0.00
Puma Biotechnology (PBYI) United States $0.137B 14.68
Oncobiologics (OTLK) United States $0.136B 0.00
Adherex Technologies (FENC) United States $0.131B 119.75
Seres Therapeutics (MCRB) United States $0.131B 0.00
Annovis Bio (ANVS) United States $0.127B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.127B 0.00
Rani Therapeutics Holdings (RANI) United States $0.125B 0.00
INmune Bio (INMB) United States $0.124B 0.00
Seer (SEER) United States $0.122B 0.00
23andMe Holding (ME) United States $0.121B 0.00
Werewolf Therapeutics (HOWL) United States $0.119B 0.00
PDS Biotechnology (PDSB) United States $0.119B 0.00
Leap Therapeutics (LPTX) United States $0.118B 0.00
Immunic (IMUX) United States $0.118B 0.00
Adicet Bio (ACET) United States $0.116B 0.00
Benitec Biopharma (BNTC) United States $0.114B 0.00
Elutia (ELUT) United States $0.112B 0.00
Coya Therapeutics (COYA) United States $0.112B 0.00
Allakos (ALLK) United States $0.108B 0.00
Invivyd (IVVD) United States $0.108B 0.00
Alto Neuroscience (ANRO) United States $0.108B 0.00
Genelux (GNLX) United States $0.107B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.105B 0.00
Cellectis S.A (CLLS) France $0.102B 0.00
Genenta Science S.p.A (GNTA) Italy $0.097B 0.00
BioAtla (BCAB) United States $0.097B 0.00
FibroBiologics (FBLG) United States $0.097B 0.00
Agenus (AGEN) United States $0.096B 0.00
I-Mab (IMAB) China $0.096B 0.00
Bluebird Bio (BLUE) United States $0.095B 0.00
HilleVax (HLVX) United States $0.095B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.094B 0.00
Cidara Therapeutics (CDTX) United States $0.094B 0.00
InflaRx (IFRX) Germany $0.092B 0.00
Oncolytics Biotech (ONCY) Canada $0.092B 0.00
Aileron Therapeutics (ALRN) United States $0.088B 0.00
BeyondSpring (BYSI) United States $0.087B 0.00
MediciNova (MNOV) United States $0.086B 0.00
Coherus BioSciences (CHRS) United States $0.086B 0.00
IO Biotech (IOBT) Denmark $0.085B 0.00
Ovid Therapeutics (OVID) United States $0.084B 0.00
X4 Pharmaceuticals (XFOR) United States $0.084B 0.00
Chimerix (CMRX) United States $0.083B 0.00
CervoMed (CRVO) United States $0.083B 0.00
Renovaro (RENB) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
VistaGen Therapeutics (VTGN) United States $0.083B 0.00
Cue Biopharma (CUE) United States $0.082B 0.00
Galena Biopharma (SLS) United States $0.079B 0.00
DBV Technologies S.A (DBVT) France $0.079B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
CytomX Therapeutics (CTMX) United States $0.078B 7.14
BioHarvest Sciences (CNVCF) Canada $0.077B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.076B 0.00
ALX Oncology Holdings (ALXO) United States $0.074B 0.00
Adlai Nortye (ANL) Cayman Islands $0.073B 0.00
TELA Bio (TELA) United States $0.071B 0.00
ZIVO Bioscience (ZIVO) United States $0.071B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.20
Rapt Therapeutics (RAPT) United States $0.070B 0.00
Boundless Bio (BOLD) United States $0.070B 0.00
Omega Therapeutics (OMGA) United States $0.068B 0.00
Syros Pharmaceuticals (SYRS) United States $0.068B 0.00
Entera Bio (ENTX) Israel $0.068B 0.00
Connect Biopharma Holdings (CNTB) United States $0.066B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.066B 0.00
Aerovate Therapeutics (AVTE) United States $0.065B 0.00
Monopar Therapeutics (MNPR) United States $0.064B 0.00
Shattuck Labs (STTK) United States $0.064B 0.00
OnKure Therapeutics (OKUR) United States $0.060B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Precision BioSciences (DTIL) United States $0.059B 0.00
Immuneering (IMRX) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Imunon (IMNN) United States $0.058B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.057B 0.00
Theratechnologies (THTX) Canada $0.057B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Quince Therapeutics (QNCX) United States $0.051B 0.00
Affimed (AFMD) Germany $0.051B 0.00
Vor Biopharma (VOR) $0.051B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.049B 0.00
Aadi Bioscience (AADI) United States $0.049B 0.00
Equillium (EQ) United States $0.049B 0.00
Immix Biopharma (IMMX) United States $0.047B 0.00
Elicio Therapeutics (ELTX) United States $0.046B 0.00
Fortress Biotech (FBIO) United States $0.046B 0.00
HOOKIPA Pharma (HOOK) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.045B 0.00
Clene (CLNN) United States $0.044B 0.00
Atara Biotherapeutics (ATRA) United States $0.044B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.044B 0.00
Xilio Therapeutics (XLO) United States $0.044B 0.00
Intensity Therapeutics (INTS) United States $0.043B 0.00
Rallybio (RLYB) United States $0.042B 0.00
CalciMedica (CALC) United States $0.042B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Passage Bio (PASG) United States $0.039B 0.00
NextCure (NXTC) United States $0.039B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Lexaria Bioscience (LEXX) Canada $0.037B 0.00
Celularity (CELU) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.036B 0.00
Eyenovia (EYEN) United States $0.035B 0.00
Elevation Oncology (ELEV) United States $0.035B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
Dare Bioscience (DARE) United States $0.034B 0.00
KALA BIO (KALA) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Ocean Biomedical (OCEA) United States $0.032B 0.00
Dyadic (DYAI) United States $0.032B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Longeveron (LGVN) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Femasys (FEMY) United States $0.031B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.030B 0.00
Aligos Therapeutics (ALGS) United States $0.030B 0.00
BRIACELL THERAP (BCTX) Canada $0.030B 0.00
BioXcel Therapeutics (BTAI) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Curis (CRIS) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
Bolt Biotherapeutics (BOLT) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Pluri (PLUR) Israel $0.025B 0.00
LakeShore Biopharma (LSB) China $0.025B 0.00
RenovoRx (RNXT) United States $0.025B 0.00
Spruce Biosciences (SPRB) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.024B 0.00
Aprea Therapeutics (APRE) United States $0.023B 0.00
Cognition Therapeutics (CGTX) United States $0.023B 0.00
Beyond Air (XAIR) United States $0.023B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
Athira Pharma (ATHA) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
BioAffinity Technologies (BIAF) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Cadrenal Therapeutics (CVKD) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.016B 0.00
Tenax Therapeutics (TENX) United States $0.016B 0.00
Sensei Biotherapeutics (SNSE) United States $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Cingulate (CING) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.013B 0.00
Biora Therapeutics (BIOR) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Apollomics (APLM) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
NKGen Biotech (NKGN) United States $0.011B 0.00
Vincerx Pharma (VINC) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
Edesa Biotech (EDSA) Canada $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Carmell (CTCX) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Hoth Therapeutics (HOTH) United States $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
Exicure (XCUR) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Bionomics (BNOX) Australia $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Elevai Labs (ELAB) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00